Sabay, Maudina T.
HRN: 23-65-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/06/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/06/2023
09/13/2023
IV
4.5g
Q8H
Cholecystitis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes